13th Annual Clinical Trials Summit 2022
13th Annual Clinical Trials Summit 2022 in Mumbai

From: 19 May 2022 To: 19 May 2022

Start Time: 09:00 AM End Time: 05:00 PM

Venue: Andheri Kurla Road, Andheri ( E ), Mumbai

Created By: Kavitha

13th Annual Clinical Trials Summit 2022

Event Description

mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">13th
Annual Clinical Trials Summit 2022


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555"> 


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">19th May 2022, Kohinoor Continental Hotel, Mumbai, India
major-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial;color:#555555">


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">13th
Annual Clinical Trials Summit 2022 will provide a platform to discuss on the
futuristic advancements in clinical trials and clinical research. This multidisciplinary
program involves broad participation of people from clinical trials community
from around the globe who are focused on learning more about clinical research,
clinical trials planning and management.


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555"> 


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">This conference intends to focus on the global health and
clinical trials around the world. Bioethics, regulations, patient recruitment,
site selection, real-world data, data integration & Strategy, outsourcing,
vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical
auditing & financial planning and other significant topics that play a key
role in clinical trials will be addressed along with innovative sessions on new
technologies, effective and quality collaborations.


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">SPONSORS:


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555"> 


"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">Tenthpin, Clinevo Technologies, Advity Research, Ontime Globe
Kyarrier, Innvocept Solutions, Target Institute Of Medical Education &
Research, Zuellig Pharma, Chitkara University


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">DELEGATE
REGISTRATION:
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">E-mail
mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:major-latin;
mso-bidi-font-family:Arial">kavitha@virtueinsight.co.in
major-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
major-latin;mso-bidi-font-family:Arial;color:#555555">  or Call - + 91 44 24762472/ +91 9361957193



  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Standard
    Price   - (INR 15,000 + GST (18%) per delegate)



mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Conference
Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest
and queries
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">KEY
SPEAKERS:
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">



  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">KAMAL K
    HALDER,
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial"> ADCI, CDSCO
    (WZ)

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">MUKESH KUMAR, 
    major-latin;mso-fareast-font-family:"Times New Roman";mso-hansi-theme-font:
    major-latin;mso-bidi-font-family:Arial">Senior Vice President & Head,
    Clinical R&D, Cipla

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SADHNA
    JOGLEKAR, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Senior Vice
    President, Global Medical Affairs, Sun Pharma

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">PRATIK
    SHAH, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Vice
    President Medical Affairs, Bharat Serums and Vaccines

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">RAVI SEKHAR
    KASIBHATTA, 
    "Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:
    Arial">Senior Vice President, Clinical Research, Lupin

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">MANISH
    SHAH, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
    Vice President, Wockhardt

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SANDESH
    SAWANT, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Senior
    Director, Medical Services Head - Clinical Trials, Cipla

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">RAGHURAM
    JANAPAREDDY, 
    "Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:
    Arial">Partner & Managing Director – India, Tenthpin

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">DIVAKAR
    KOLLI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
    Director and Head - Clinical & Non-Clinical QA, Cipla

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">TUSHAR
    SAKPAL, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Director -
    Clinical Data Standards & Automation, Novartis

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">MILIND
    ANTANI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Leader,
    Pharma and Healthcare, Nishith Desai Associates

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">YASMIN
    SHENOY, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Director-Regulatory
    Affairs, Sanofi

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ANIKET
    JOSHI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
    Global Portfolio Delivery Director, Novartis

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">RISHI
    JAIN, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Medical
    Director, AbbVie

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">DILIP
    PAWAR, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head -
    Medical Affairs and Pharmacovigilance, Unichem Laboratories

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">CHIRAG
    TRIVEDI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Clinical
    Study Unit Cluster Head, Sanofi

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">KEDAR
    NAYAK, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head -
    Clinical Development, GSK

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ARUN
    BHATT, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Consultant –
    Clinical Research & Development

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">AMITA
    BHAVE, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head
    Regulatory Affairs GDD, Novartis

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">HARSHAD
    KOTHAWADE, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head-Regulatory
    Management & Trade Compliance, Merck

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SADANAND
    KULKARNI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head-Medical,
    Regulatory, Vigilance, Quality, Fresenius Kabi

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">VAIBHAV
    SALVI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Head –
    Medical Information, Asia, Sanofi

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">INDRANIL
    PURKAIT, S
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">r. General
    Manager and Head Medical Affairs, Ipca Laboratories

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ASHWANI
    PANDITA , 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">General
    Manager Quality Management & Training, Global Clinical Research Operations, Glenmark

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">VALLABH
    DESHPANDE, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">HOD PV
    Operations, Glenmark

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">VISHWAS
    SOVANI, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Founder
    Director, Pharmawisdom

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">GANESH
    KADHE, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Senior
    Leadership Team Member, Scientific & Medical Affairs, Abbott
    Nutrition

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">SAKHARAM
    GARALE, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Founder &
    CEO, Renovare Healthcare Solutions

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">ROSHAN
    PAWAR, 
    mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Associate
    General Manager, Alkem Laboratories



mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Plus
more joining soon


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">KEY
THEMES DISCUSSED:
mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">



  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">The growth of
    hybrid trial and virtual trials in India – Where we are?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Better
    patient recruitment and retention – Can be achieved by DCT?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Digital
    transformation and AI in clinical trials

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">What are key
    challenges in patient safety? Ways to overcome and better alternatives

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Risk-based
    monitoring (RBM) – Is ensuring patient safety?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Clinical
    trial design and implementation – How technology makes an easier way?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Wearable
    devices, remote monitoring and virtual trials – Risk and benefits

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Key market
    trends and challenges driving opportunities and outsourcing

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">End-to-end
    strategic partnership and managing the communications gap in CROs

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">How can
    sponsors successfully manage the EU CTR change?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Technology
    accelerates new age clinical research

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Are the
    regulations sufficient in clinical trials and what needs to be done?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Remote
    clinical research – Risks and chances

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">How RWE is
    transforming clinical trials?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">How do we
    deal with privacy concerns around RWD?

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Ensuring and
    maintaining compliance with the rules and regulations.

  • mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
    mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">Be part of a
    major networking opportunity



mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">WHO
SHOULD ATTEND AND WHO YOU’LL MEET:
"Times New Roman";mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;
color:#555555">


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">CIOs,
CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from
the following areas:


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Clinical
Research & Development, Clinical Research Services, Clinical Operations,
Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs,
Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study
Design, Safety Surveillance, Subject Recruitment, E-Clinical System


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555"> 


mso-ascii-theme-font:major-latin;mso-fareast-font-family:"Times New Roman";
mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial;color:#555555">Get
more from the event, with a broader scope bringing the whole communications
value chain together. Enjoy and make the best out of our dedicated networking
time, meet the leading international vendors showcasing the products of
tomorrow in the co-located exhibition. Expand your knowledge of the latest
business models and strategies in the high-level conference.


major-latin;mso-hansi-theme-font:major-latin"> 
Share This Event


Total Event Views = 46
Organizer Details

Name: Kavitha


Similar Events in Mumbai

Essential Etiquette Course

Essential Etiquette Course event in Mumbai

International Education Fair May 2022

International Education Fair May 2022 event in Mumbai

9-DAYS ETIQUETTE BOOTCAMP - Teens and Pre-teens Summer Fun-learning

9-DAYS ETIQUETTE BOOTCAMP - Teens and Pre-teens Summer Fun-learning event in Mumbai

UPCOMING WORKSHOP WITH PERSONIFY GLOBAL ACADEMY

UPCOMING WORKSHOP WITH PERSONIFY GLOBAL ACADEMY event in Mumbai